Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Revenio Group Oyj
  6. News
  7. Summary
    REG1V   FI0009010912

REVENIO GROUP OYJ

(REG1V)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Revenio Group Corporation: Transfer of the Company's own shares

05/28/2021 | 07:06am EDT

Revenio Group Corporation, Stock Exchange Release, May 28, 2021 at 14.05

Transfer of the Company's own shares

Revenio Group Corporation has transferred on May 26, 2021 1,046 shares (REG1V) to the members of the Board of Directors as part of remuneration of the Board.

Revenio Group Corporation's AGM decided on March 17, 2021 that 40% of the fee paid to a board member should be paid in company shares while 60% will comprise a monetary payment. The AGM decided that the Chair of the Board be entitled to an annual emolument of EUR 48,000, the Board members who act as the Chairman of the Committee be entitled to an annual emolument of EUR 30,000 and the other Board members to an annual emolument of EUR 24,000. The share payment will be valued using the weighted average value of the share on the day following the release of the Interim Report January 1- March 31, 2021.

As a result of these transfers, the share-based board member fees have been completely settled for the year 2021. Revenio Group Corporation now holds a total of 111,546 of its own shares.

Revenio Group Corporation

Board of Directors

For further information, please contact:
Jouni Toijala, CEO, tel.  +358 50 484 0085
jouni.toijala@revenio.fi
www.revenio.fi

DISTRIBUTION:

Nasdaq Helsinki Oy
Financial Supervisory Authority (FIN-FSA)
Principal media

www.revenio.fi 

Revenio Group in brief

Revenio is a global leader in ophthalmological devices and solutions. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), retinal imaging devices, and perimeters under the iCare brand. In addition, Revenio Group’s eye care software platform Oculo combines clinical communication, telehealth, remote patient monitoring and data-analytics capabilities.

The Revenio Group comprises Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Revenio Australia Pty Ltd, Done Medical Oy, and Oscare Medical Oy.

In 2020, the Group's net sales totaled EUR 61.1 million, with its operating profit standing at MEUR 17.1. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

© Modular Finance, source Nordic Press Releases

All news about REVENIO GROUP OYJ
09/20REVENIO OYJ : Group Corporation - Managers' Transactions
AQ
08/05REVENIO GROUP CORPORATION : Half-year financial report 1 January-30 June 2021
AQ
08/05Revenio Group Oyj Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/04REVENIO GROUP CORPORATION : Revenio updates its financial guidance for 2021
AQ
08/04Revenio Group Corporation Reaffirms Earnings Guidance for the Full Year 2021
CI
07/27REVENIO GROUP CORPORATION : Invitation to Revenio's audiocast and teleconference in relati..
AQ
06/18REVENIO GROUP CORPORATION : Hanna Vuornos appointed Director, People&Culture and as a memb..
AQ
06/18Revenio Group Corporation Appoints Hanna Vuornos as Director, People&Culture and as a M..
CI
06/15REVENIO GROUP CORPORATION : Increased number of shares entered into trade register
AQ
05/28REVENIO GROUP CORPORATION : Transfer of the Company's own shares
AQ
More news
Financials
Sales 2021 78,0 M 91,1 M 91,1 M
Net income 2021 17,3 M 20,1 M 20,1 M
Net Debt 2021 2,45 M 2,86 M 2,86 M
P/E ratio 2021 85,9x
Yield 2021 0,62%
Capitalization 1 480 M 1 731 M 1 727 M
EV / Sales 2021 19,0x
EV / Sales 2022 15,8x
Nbr of Employees 167
Free-Float 86,2%
Chart REVENIO GROUP OYJ
Duration : Period :
Revenio Group Oyj Technical Analysis Chart | REG1V | FI0009010912 | MarketScreener
Technical analysis trends REVENIO GROUP OYJ
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 55,70 €
Average target price 62,87 €
Spread / Average Target 12,9%
EPS Revisions
Managers and Directors
Jouni Erik Toijala President & Chief Executive Officer
Robin Allan Pulkkinen Chief Financial Officer
Pekka Veikko Juhani R÷nkń Chairman
Mika Salkola Director-Research & Development
Ari Isomńki Operations Director
Sector and Competitors
1st jan.Capi. (M$)
REVENIO GROUP OYJ10.74%1 731
SARTORIUS AG86.09%47 707
BIOTAGE AB (PUBL)73.81%1 810
CELLAVISION AB (PUBL)32.77%1 117
VAREX IMAGING CORPORATION67.27%1 100
ANGLE PLC151.31%386